Le capsule orali di BPC-157 contengono il pentadecapeptide Body Protection Compound-157 in un formato di capsule gastroprotette (rivestimento enterico HPMC) per la ricerca sulla biodisponibilit orale
1 H NMR (500 MHz, DMSO) 7.95 (t, J = 38.4 Hz, 5H), 7.41 (p, J = 5.1, 3.9 Hz, 18H), 7.23 (d, J = 7.4 Hz, 2H), 7.09 (d, J = 7.4 Hz, 12H), 6.96 (d, J = 19.0 Hz, 2H), 6.70 (q, J = 9.2, 8.1 Hz, 4H), 4.56 (d, J = 54.2 Hz, 2H), 4.18 (d, J = 69.9 Hz, 3H), 3.56 (tt, J = 18.3, 9.3 Hz, 7H), 3.03 2.77 (m, 10H), 1.66 1.20 (m, 54H)
Monitoring and bloodwork requirements Any researcher considering this combination without comprehensive monitoring is making a serious mistake
Genomic studies indicate that GHK-Cu influences the expression of over 4,000 human genes, approximately 6% of the human genome, including genes involved in DNA repair, proteasome function, oxidative stress response, and anti-inflammatory pathways
The bottom line When comparing AOD 9604 vs
In fact, oral supplements can lose up to 50% or more of their potency during digestion
